Phosphatidylserine binding directly regulates TIM-3 function.

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Co-signaling receptors modulate T cell receptor (TCR) activity, with PD-1 blockade a key immuno-oncology strategy.
• T cell immunoglobulin and mucin domain containing-3 (TIM-3) is a poorly understood co-signaling receptor with unclear ligand interactions and functional roles.
• Understanding TIM-3 regulation is crucial for developing novel immune modulation therapies.

Purpose of the Study:

• To elucidate the functional ligands regulating TIM-3 activity.
• To determine TIM-3's role in T cell activation pathways.
• To investigate the therapeutic potential of targeting TIM-3-ligand interactions.

Main Methods:

• Utilized Jurkat T cells to study TCR-induced signaling pathways.
• Investigated TIM-3's interaction with phosphatidylserine (PS) using mutation and antibody blockade.
• Assessed NF-κB signaling, IL-2 secretion, and CD28 phosphorylation.

Main Results:

• TIM-3 binding to phosphatidylserine (PS) was identified as a key regulatory mechanism.
• TIM-3 promotes NF-κB signaling and IL-2 secretion upon TCR stimulation.
• PS binding to TIM-3 enhances signaling, which can be blocked by targeting the PS-binding site.

Conclusions:

• Phosphatidylserine is a critical functional ligand for TIM-3.
• TIM-3 acts as a co-stimulatory receptor in T cells, promoting key signaling events.
• These findings provide a basis for exploiting TIM-3 and its interaction with PS in cancer immunotherapy.